Friess Associates LLC Medtronic PLC Transaction History

Friess Associates LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$72.92 - $121.3 $3.1 Million - $5.15 Million	-42,470 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$104.49 - $114.54 $916,377 - $1 Million	8,770 Added 26.02%	42,470 $4.82 Million
Q3 2019 Nov 14, 2019	BUY	$98.02 - $111.18 $3.3 Million - $3.75 Million	33,700 New	33,700 $3.66 Million
Q4 2017 Feb 14, 2018	SELL	$76.93 - $83.5 $2.62 Million - $2.85 Million	-34,100 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$77.71 - $84.6 $2.65 Million - $2.88 Million	34,100	34,100 $2.65 Million

2,297

1.03B

8.04M

7.22M

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $120B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

Get notified when there are updates to the investment portfolio of Friess Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Friess Associates LLC with notifications on news.